2 completed, 1 active not recruiting, 1 recruiting. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Not applicable | 1 | Recruiting 1 |
Follow Neuromuscular Blockade Reversal Agent: new trials by email Literature Review of Neuromuscular Blockade Reversal Agent trials Research Report on Neuromuscular Blockade Reversal Agent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Neostigmine and Sugammadex on the Optic Nerve Sheath Diameter Sugammadex 2 mg/kg, Neostigmine + Atropine - Neuromuscular Blockade Reversal Agent | Phase 4 | Completed | Cukurova University | 86 | 2026-06-25 | 2026-10-21 |
| Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal Sugammadex 1 mg/kg Group, Sugammadex 2 mg/kg Group, Sugammadex 4 mg/kg Group - Neuromuscular Blockade Reversal Agent, Perioperative Complications | Not applicable | Recruiting | Wonkwang University Hospital | 240 | 2025-07-01 | 2026-07-07 |
| NMBA Reversal and Postoperative Urinary Retention Choice of reversal agent (sugammadex or neostigmine [with muscaranic antagonist]) - Neuromuscular Blocking Agents, Urinary Retention After Procedure | Active not recruiting | Beth Israel Deaconess Medical Center | 70000 | 2025-06-08 | 2026-01-23 | |
| Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine Sugammadex, Neostigmine - Neuromuscular Blockade Reversal Agent, Sugammadex | Phase 4 | Completed | Seoul National University Bundang Hospital | 77 | 2020-02-24 | 2020-12-24 |
Trismus (1) · Urinary Retention (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Male Urogenital Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Neuromuscular Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Spasm (1) · Urination Disorders (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Sugammadex (4) · Neostigmine (3) · Atropine (1) · Epinephrine (1) · Population Groups (1) · Pyridostigmine Bromide (1) · S 1 (combination) (1)
Beth Israel Deaconess Medical Center (1) · Cukurova University (1) · Seoul National University Bundang Hospital (1) · Wonkwang University Hospital (1)
South Korea (2) · Turkey (Türkiye) (1) · United States (1)
Cheolhyeong Lee, MD (1) · Ersel Gulec, MD (1) · Jiwon Han, Ms (1) · Luca J Wachtendorf, MD (1) · Maximilian S Schaefer, MD, PhD (1)